Home › Conferences › ESMO IO
ESMO Immuno-Oncology and Advanced Therapies Congress 2026
ESMO Immuno-Oncology and Advanced Therapies Congress 2026 takes place December 14 to 16, 2026 in London, UK.
Dec 14-16, 2026 · London, UK · Immuno-oncology, cell and gene therapy.
DatesDec 14-16, 2026
LocationLondon, UK
Therapeutic focusImmuno-oncology, cell and gene therapy
Biotech presenters sourced0
Organiseresmo.org
Biotech presenters
None sourced yet. A company is listed only when its own SEC filing or press release commits to this edition; the organiser's abstract list usually lands a few weeks before the meeting.
About · Corrections · Changelog · Glossary · Methodology
Not affiliated with ESMO IO or its organizer. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.
Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.
© 2026 pdufa.bio. All rights reserved.
Not affiliated with ESMO IO or its organizer. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.
Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.
© 2026 pdufa.bio. All rights reserved.
What presenting companies' shares did, across the whole study
Across 1,425 presentations at major medical meetings from 2017 to 2026, the median presenting company's stock moved −0.03% in the 30 trading days before the meeting (49.8% rose) and −1.59% in the 5 trading days after (39.4% rose). Small caps: +2.75% before (n=298); nano caps: −7.86% (n=108). The middle half of all presenters ranged from −10.41% to +13.58%. The study is anchored on the meeting start date, not on the abstract release; the true catalyst may be earlier. This measures what happened; it is not a forecast for any company. Full study, with the method and its limits.
How ESMO IO stocks have traded historically
Median share-price move around a presentation, measured across 1425 all tracked conference presentations in our study (2017-2026), because our study holds fewer than 12 ESMO IO events on their own.
30 days before-0.03% 50% rose · n=1425
10 days before+0.63% 52% rose · n=1425
Presentation day-0.56% 44% rose · n=1425
5 days after-1.59% 39% rose · n=1425
10 days after-1.93% 40% rose · n=1425
Read the whole row, not just the first line: across this study stocks have drifted up into these meetings and down out of them, and the effect is largest in the smallest companies. Medians are shown because a handful of large moves pulls an average away from the typical case. This is a historical distribution for a cohort of companies, not a forecast for any single company, and not investment advice. Methodology and the full study.
FAQ
When is ESMO IO 2026?
ESMO Immuno-Oncology and Advanced Therapies Congress 2026 runs December 14-16, 2026 in London, UK. The date comes from the organiser's own announcement; check the organiser's site for the final programme.
Which biotech companies are presenting at ESMO IO 2026?
None sourced yet. We list a company as presenting only when its own SEC filing or press release commits to this edition -- abstract titles and rumours don't qualify. The conferences page updates as filings land.
Why do medical conference dates matter for biotech stocks?
Trial results are often presented first at medical meetings, so a company's announced presentation is a dated, public catalyst. We publish a study of how biotech stocks have historically traded into conference presentations on the research page; it is historical measurement, not a prediction, and none of this is investment advice.